TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
Pharmex AS
Closing information (x1000 EUR)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
2,206
|
2,154
|
1,720 |
Financial expenses |
68
|
79
|
10 |
Earnings before taxes |
322
|
317
|
234 |
Total assets |
972
|
876
|
913 |
Current assets |
972
|
876
|
913 |
Current liabilities |
339
|
272
|
376 |
Equity capital |
614
|
577
|
499 |
- share capital |
53
|
57
|
60 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
63.2%
|
65.9%
|
54.7% |
Turnover per employee | |||
Profit as a percentage of turnover |
14.6%
|
14.7%
|
13.6% |
Return on assets (ROA) |
40.1%
|
45.2%
|
26.7% |
Current ratio |
286.7%
|
322.1%
|
242.8% |
Return on equity (ROE) |
52.4%
|
54.9%
|
46.9% |
Change turnover |
189
|
525
|
372 |
Change turnover % |
9%
|
32%
|
28% |
Chg. No. of employees | |||
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.